載入...
Current and future antimicrobial treatment of gonorrhoea – the rapidly evolving Neisseria gonorrhoeae continues to challenge
Neisseria gonorrhoeae has developed antimicrobial resistance (AMR) to all drugs previously and currently recommended for empirical monotherapy of gonorrhoea. In vitro resistance, including high-level, to the last option ceftriaxone and sporadic failures to treat pharyngeal gonorrhoea with ceftriaxon...
Na minha lista:
| 發表在: | BMC Infect Dis |
|---|---|
| 主要作者: | |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
BioMed Central
2015
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4546108/ https://ncbi.nlm.nih.gov/pubmed/26293005 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12879-015-1029-2 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|